Francesco Giorgino (F Giorgino)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 99

Top Topics

Top Venues

Diabetes, obesity & metabolism

Journal of endocrinological investigation

International journal of molecular sciences

Diabetes/metabolism research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

I Caruso, L Di Gioia, S Di Molfetta, M Caporusso, A Cignarelli, G P Sorice, L Laviola, Francesco Giorgino
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. Journal of endocrinological investigation (2024)
Irene Caruso, Francesco Giorgino
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future. Endocrine 84 (3) (2024)
Stefano Del Prato, Francesco Giorgino, Kirk Szafranski, Yeesha Poon
Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective. Diabetes, obesity & metabolism 26 (9) (2024)
Francesca Torresan, Clelia Iacobone, Francesco Giorgino, Maurizio Iacobone
Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas. International journal of molecular sciences 25 (13) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Irene Caruso, Francesco Giorgino
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future. Endocrine 84 (3) (2024)
Sarantis Livadas, Bulent O Yildiz, George Mastorakos, Alessandra Gambineri, Duarte Pignatelli, Francesco Giorgino, Marianne Skovsager Andersen, Barbara Obermayer-Pietsch, Djuro Macut, null null
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire. European journal of endocrinology 191 (2) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Sarantis Livadas, Bulent O Yildiz, George Mastorakos, Alessandra Gambineri, Duarte Pignatelli, Francesco Giorgino, Marianne Skovsager Andersen, Barbara Obermayer-Pietsch, Djuro Macut, null null
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire. European journal of endocrinology (2024)
Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer, Carina Mauersberger, Oliver Schnell, Francesco Giorgino
Practical strategies to manage obesity in type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer, Carina Mauersberger, Oliver Schnell, Francesco Giorgino
Practical strategies to manage obesity in type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Sarantis Livadas, Bulent O Yildiz, George Mastorakos, Alessandra Gambineri, Duarte Pignatelli, Francesco Giorgino, Marianne Skovsager Andersen, Barbara Obermayer-Pietsch, Djuro Macut, null null
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire. European journal of endocrinology 191 (2) (2024)
Sergio Di Molfetta, Ludovico Di Gioia, Irene Caruso, Angelo Cignarelli, Suetonia C Palmer, Patrizia Natale, Giovanni F M Strippoli, Gian Pio Sorice, Francesco Giorgino, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetes/metabolism research and reviews 40 (6) (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care (2024)
Irene Caruso, Francesco Giorgino
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future. Endocrine 84 (3) (2024)
Helena W Rodbard, Katharine Barnard-Kelly, Andreas F H Pfeiffer, Carina Mauersberger, Oliver Schnell, Francesco Giorgino
Practical strategies to manage obesity in type 2 diabetes. Diabetes, obesity & metabolism (2024)
Stefano Del Prato, Francesco Giorgino, Kirk Szafranski, Yeesha Poon
Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective. Diabetes, obesity & metabolism (2024)
Francesco Giorgino, Denise R Franco, Claudia Nicolay, Andrea Hemmingway, Angel Rodríguez, Russell J Wiese
Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials. Diabetes care 47 (6) (2024)
A Natalicchio, N Marrano, M Montagnani, M Gallo, A Faggiano, M C Zatelli, A Argentiero, M Del Re, S D'Oronzo, S Fogli, T Franchina, D Giuffrida, S Gori, A Ragni, G Marino, R Mazzilli, M Monami, L Morviducci, V Renzelli, A Russo, L Sciacca, E Tuveri, A Cortellini, M Di Maio, R Candido, F Perrone, G Aimaretti, A Avogaro, N Silvestris, Francesco Giorgino
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view. Journal of endocrinological investigation (2024)
Irene Caruso, Francesco Giorgino
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future. Endocrine 84 (3) (2024)
Irene Caruso, Francesco Giorgino
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future. Endocrine (2024)
Francesca Torresan, Clelia Iacobone, Francesco Giorgino, Maurizio Iacobone
Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas. International journal of molecular sciences 25 (13) (2024)
Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Rossella D'Oria, Valentina Annamaria Genchi, Cristina Caccioppoli, Angelo Cignarelli, Francesco Giorgino, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
The p66 Shc Redox Protein and the Emerging Complications of Diabetes. International journal of molecular sciences 25 (1) (2023)
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Glucagon in type 2 diabetes: Friend or foe? Diabetes/metabolism research and reviews (2023)
Raffaele Napoli, Cesare Berra, Andrei-Mircea Catarig, Chiara Di Loreto, Emily Donatiello, Tina Landsvig Berentzen, Dario Pitocco, Francesco Giorgino
Once-weekly semaglutide use in patients with type 2 diabetes: real-world data from the SURE Italy observational study. Diabetes, obesity & metabolism (2023)
Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Rossella D'Oria, Valentina Annamaria Genchi, Cristina Caccioppoli, Angelo Cignarelli, Francesco Giorgino, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
The p66 Shc Redox Protein and the Emerging Complications of Diabetes. International journal of molecular sciences 25 (1) (2023)
Francesco Giorgino, Bruno Guerci, Martin Füchtenbusch, Jérémie Lebrec, Kristina Secnik Boye, Marco Orsini Federici, Elke Heitmann, Anne Dib, Maria Yu, Hélène Sapin, Luis-Emilio Garcia-Perez
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes. Diabetes, obesity & metabolism (2023)
Valerio Renzelli, Marco Gallo, Lelio Morviducci, Giampiero Marino, Alberto Ragni, Enzo Tuveri, Antongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, Maria Chiara Zatelli, Monica Montagnani, Stefano Fogli, Dario Giuffrida, Antonella Argentiero, Romano Danesi, Stella D'Oronzo, Stefania Gori, Tindara Franchina, Antonio Russo, Matteo Monami, Laura Sciacca, Saverio Cinieri, Annamaria Colao, Angelo Avogaro, Graziano Di Cianni, Francesco Giorgino, Nicola Silvestris
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer. Cancers 15 (17) (2023)
Matthias Blüher, Mohini Aras, Louis J Aronne, Rachel L Batterham, Francesco Giorgino, Li-Nong Ji, Kirsi H Pietiläinen, Oliver Schnell, Elena Tonchevska, John P H Wilding
New insights into the treatment of obesity. Diabetes, obesity & metabolism (2023)
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Martina Rella, Tommaso Zambetta, Ludovico Di Gioia, Mariangela Caporusso, Giancarlo Logroscino, Francesco Giorgino, Francesco Giorgino, Annalisa Natalicchio
Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity. Biomolecules 13 (1) (2023)
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Glucagon in type 2 diabetes: Friend or foe? Diabetes/metabolism research and reviews 39 (3) (2023)
Sue D Pedersen, Francesco Giorgino, Guillermo E Umpierrez, Vivian T Thieu, Angel Rodríguez, Claudia Nicolay, Laura Fernández Landó, Chrisanthi A Karanikas, Jacek Kiljanski
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme. Diabetes, obesity & metabolism (2023)
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Martina Rella, Tommaso Zambetta, Ludovico Di Gioia, Mariangela Caporusso, Giancarlo Logroscino, Francesco Giorgino, Francesco Giorgino, Annalisa Natalicchio
Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity. Biomolecules 13 (1) (2023)
Francesco Giorgino, Tadej Battelino, Richard M Bergenstal, Thomas Forst, Jennifer B Green, Chantal Mathieu, Helena W Rodbard, Oliver Schnell, Emma G Wilmot
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of diabetes science and technology (2023)
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Glucagon in type 2 diabetes: Friend or foe? Diabetes/metabolism research and reviews 39 (3) (2023)
Andrea Iannone, Patrizia Natale, Suetonia C Palmer, Antonio Nicolucci, Maria Rendina, Francesco Giorgino, Luigi Laviola, Alfredo Di Leo, Giovanni F M Strippoli
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism (2023)
Kristina S Boye, Jérémie Lebrec, Anne Dib, Elke Heitmann, Marco Orsini Federici, Maria Yu, Hélène Sapin, Annabel Barrett, Bruno Guerci, Francesco Giorgino, Martin Füchtenbusch, Luis-Emilio Garcia-Perez
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient-reported outcomes at 24 months. Diabetes, obesity & metabolism (2023)
Raffaele Napoli, Cesare Berra, Andrei-Mircea Catarig, Chiara Di Loreto, Emily Donatiello, Tina Landsvig Berentzen, Dario Pitocco, Francesco Giorgino
Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study. Diabetes, obesity & metabolism (2023)
V A Genchi, G Palma, G P Sorice, R D'Oria, C Caccioppoli, N Marrano, G Biondi, I Caruso, A Cignarelli, A Natalicchio, L Laviola, Francesco Giorgino, S Perrini
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management? Journal of endocrinological investigation (2023)
Sergio Di Molfetta, Irene Caruso, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
Professional continuous glucose monitoring in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Sergio Di Molfetta, Irene Caruso, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Martina Rella, Tommaso Zambetta, Ludovico Di Gioia, Mariangela Caporusso, Giancarlo Logroscino, Francesco Giorgino, Francesco Giorgino, Annalisa Natalicchio
Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity. Biomolecules 13 (1) (2023)
Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Rossella D'Oria, Valentina Annamaria Genchi, Cristina Caccioppoli, Angelo Cignarelli, Francesco Giorgino, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
The p66 Shc Redox Protein and the Emerging Complications of Diabetes. International journal of molecular sciences 25 (1) (2023)
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Glucagon in type 2 diabetes: Friend or foe? Diabetes/metabolism research and reviews (2023)
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Martina Rella, Tommaso Zambetta, Ludovico Di Gioia, Mariangela Caporusso, Giancarlo Logroscino, Francesco Giorgino, Francesco Giorgino, Annalisa Natalicchio
Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity. Biomolecules 13 (1) (2023)
Irene Caruso, Nicola Marrano, Giuseppina Biondi, Valentina Annamaria Genchi, Rossella D'Oria, Gian Pio Sorice, Sebastio Perrini, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Glucagon in type 2 diabetes: Friend or foe? Diabetes/metabolism research and reviews 39 (3) (2023)
G P Sorice, M Caporusso, A Cignarelli, S Perrini, A Natalicchio, Francesco Giorgino
Metformin use in pregnancy: efficacy, safety, and potential benefits. Journal of endocrinological investigation 46 (3) (2022)
S Di Molfetta, P Patruno, S Cormio, A Cignarelli, R Paleari, A Mosca, O Lamacchia, S De Cosmo, M Massa, A Natalicchio, S Perrini, L Laviola, Francesco Giorgino
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial. Journal of endocrinological investigation 45 (9) (2022)
Philip D Home, Rory J McCrimmon, Julio Rosenstock, Matthias Blüher, Katrin Pegelow, Lydie Melas-Melt, Khier Djaballah, Francesco Giorgino, null null
Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics. Diabetes, obesity & metabolism (2022)
Matthias Blüher, Antonio Ceriello, Melanie Jane Davies, Helena W Rodbard, Naveed Sattar, Oliver Schnell, Elena Tonchevska, Francesco Giorgino
Managing weight and glycaemic targets in people with type 2 diabetes-How far have we come? Endocrinology, diabetes & metabolism 5 (3) (2022)
G P Sorice, M Caporusso, A Cignarelli, S Perrini, A Natalicchio, Francesco Giorgino
Metformin use in pregnancy: efficacy, safety, and potential benefits. Journal of endocrinological investigation 46 (3) (2022)
Rossella D'Oria, Valentina Annamaria Genchi, Cristina Caccioppoli, Isabella Calderoni, Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Ludovico Di Gioia, Francesco Giorgino, Luigi Laviola
Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System. International journal of molecular sciences 23 (22) (2022)
Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, Annalisa Natalicchio, Francesco Giorgino, Luigi Laviola, Francesco Giorgino
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies. Metabolites 12 (2) (2022)
Giuseppina Biondi, Nicola Marrano, Lucia Dipaola, Anna Borrelli, Martina Rella, Rossella D'Oria, Valentina A Genchi, Cristina Caccioppoli, Immacolata Porreca, Angelo Cignarelli, Francesco Giorgino, Piero Marchetti, Leonardo Vincenti, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
The p66Shc Protein Mediates Insulin Resistance and Secretory Dysfunction in Pancreatic β-Cells Under Lipotoxic Conditions. Diabetes 71 (8) (2022)
Rory J McCrimmon, Philip Home, Alice Cheng, Francesco Giorgino, Vivian A Fonseca, Elisabeth Souhami, Agustina Alvarez, Pascaline Picard, Julio Rosenstock
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial. Diabetes, obesity & metabolism 24 (12) (2022)
Irene Caruso, Angelo Cignarelli, Luigi Laviola, Francesco Giorgino
GLP-1 Receptor Agonists for Cardiovascular Protection: A Matter of Time. Diabetes care 45 (2) (2022)
G P Sorice, M Caporusso, A Cignarelli, S Perrini, A Natalicchio, Francesco Giorgino
Metformin use in pregnancy: efficacy, safety, and potential benefits. Journal of endocrinological investigation 46 (3) (2022)
Lorenzo Piemonti, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, Pozzilli Paolo, Francesco Giorgino, Efisio Cossu, Luisa Daffonchio, Giovanni Goisis, Pier Adelchi Ruffini, Anna Rita Maurizi, Flavio Mantelli, Marcello Allegretti
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism 24 (9) (2022)
Valentina Annamaria Genchi, Erica Rossi, Celeste Lauriola, Rossella D'Oria, Giuseppe Palma, Anna Borrelli, Cristina Caccioppoli, Francesco Giorgino, Angelo Cignarelli
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism. International journal of molecular sciences 23 (15) (2022)
Sergio Di Molfetta, Antonella Daniele, Chiara Gerardi, Eleonora Allocati, Carla Minoia, Giacomo Loseto, Francesco Giorgino, Attilio Guarini, Vitaliana De Sanctis
Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi. Cancers 14 (6) (2022)
Bruno Guerci, Francesco Giorgino, Hélène Sapin, Kristina Boye, Jérémie Lebrec, Marco Orsini Federici, Elke Heitmann, Anne Dib, Martin Füchtenbusch, Luis-Emilio Garcia-Perez
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months. Diabetes, obesity & metabolism 24 (12) (2022)
Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Giuseppe Palma, Isabella Calderoni, Edoardo Siciliano, Pasquale Lops, Francesco Giorgino, Annalisa Natalicchio
Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes. International journal of molecular sciences 23 (10) (2022)
William H Polonsky, Francesco Giorgino, Julio Rosenstock, Katherine Whitmire, Elisheva Lew, Mathieu Coudert, Agustina Alvarez, Charlie J Nicholls, Rory J McCrimmon
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Diabetes, obesity & metabolism 24 (12) (2022)
G P Sorice, M Caporusso, A Cignarelli, S Perrini, A Natalicchio, Francesco Giorgino
Metformin use in pregnancy: efficacy, safety, and potential benefits. Journal of endocrinological investigation 46 (3) (2022)
Giuseppe Palma, Gian Pio Sorice, Valentina Annamaria Genchi, Fiorella Giordano, Cristina Caccioppoli, Rossella D'Oria, Nicola Marrano, Giuseppina Biondi, Francesco Giorgino, Francesco Giorgino
Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. International journal of molecular sciences 23 (13) (2022)
G P Sorice, M Caporusso, A Cignarelli, S Perrini, A Natalicchio, Francesco Giorgino
Metformin use in pregnancy: efficacy, safety, and potential benefits. Journal of endocrinological investigation 46 (3) (2022)
G P Sorice, M Caporusso, A Cignarelli, S Perrini, A Natalicchio, Francesco Giorgino
Metformin use in pregnancy: efficacy, safety, and potential benefits. Journal of endocrinological investigation (2022)
Marco Castellana, Eleonora Conte, Angelo Cignarelli, Francesco Giorgino, Andrea Giustina, Luca M Giovanella, Francesco Giorgino, Pierpaolo Trimboli
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis. Reviews in endocrine & metabolic disorders 21 (1) (2021)
Paola Pontrelli, Francesca Conserva, Rossella Menghini, Michele Rossini, Alessandra Stasi, Chiara Divella, Viviana Casagrande, Claudia Cinefra, Mariagrazia Barozzino, Simona Simone, Francesco Pesce, Giuseppe Castellano, Giovanni Stallone, Anna Gallone, Francesco Giorgino, Massimo Federici, Loreto Gesualdo
Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice. International journal of molecular sciences 22 (10) (2021)
Angelo Cignarelli, Valentina Annamaria Genchi, Rossella D'Oria, Fiorella Giordano, Irene Caruso, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Role of Glucose-Lowering Medications in Erectile Dysfunction. Journal of clinical medicine 10 (11) (2021)
Irene Caruso, Angelo Cignarelli, Luigi Laviola, Francesco Giorgino
Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure? Diabetes, obesity & metabolism 23 (9) (2021)
Valentina Annamaria Genchi, Rossella D'Oria, Giuseppe Palma, Cristina Caccioppoli, Angelo Cignarelli, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino, Sebastio Perrini
Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine? International journal of molecular sciences 22 (12) (2021)
Nicola Marrano, Rosaria Spagnuolo, Giuseppina Biondi, Angelo Cignarelli, Sebastio Perrini, Leonardo Vincenti, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
Effects of Extra Virgin Olive Oil Polyphenols on Beta-Cell Function and Survival. Plants (Basel, Switzerland) 10 (2) (2021)
A Cignarelli, A Ciavarella, M Barbaro, S Kounaki, A Di Trani, V A Falcone, V N Quaranta, A Natalicchio, L Laviola, O Resta, Francesco Giorgino, S Perrini
Postprandial glucose and HbA1c are associated with severity of obstructive sleep apnoea in non-diabetic obese subjects. Journal of endocrinological investigation 44 (12) (2021)
Marco Castellana, Claudia Parisi, Sergio Di Molfetta, Ludovico Di Gioia, Annalisa Natalicchio, Francesco Giorgino, Angelo Cignarelli, Luigi Laviola, Francesco Giorgino
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. BMJ open diabetes research & care 8 (1) (2021)
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Angelo Cignarelli, Sebastio Perrini, Luigi Laviola, Francesco Giorgino, Annalisa Natalicchio
Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity. Biomolecules 11 (2) (2021)
Marta Baviera, Stefano Genovese, Vito Lepore, Pierluca Colacioppo, Fabio Robusto, Mauro Tettamanti, Antonio D'Ettorre, Fausto Avanzini, Ida Fortino, Antonio Nicolucci, Maria C Roncaglioni, Francesco Giorgino
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts. Diabetes, obesity & metabolism 23 (7) (2021)
Rossella D'Oria, Rossella Schipani, Anna Leonardini, Annalisa Natalicchio, Francesco Giorgino, Angelo Cignarelli, Luigi Laviola, Francesco Giorgino
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor. Oxidative medicine and cellular longevity 2020 (2020)
Angelo Cignarelli, Andrea Sansone, Irene Caruso, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Emmanuele A Jannini, Francesco Giorgino
Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis. Journal of diabetes science and technology 14 (6) (2020)
Francesco Giorgino, Jiten Vora, Peter Fenici, Anna Solini
Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk. Cardiovascular diabetology 19 (1) (2020)
Francesco Giorgino, Jiten Vora, Peter Fenici, Anna Solini
Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients? Diabetes, obesity & metabolism 22 (9) (2020)
Nicola Morea, Chang Ye, Josep Vidal, Vanita R Aroda, Minzhi Liu, Aramesh Saremi, Francesco Giorgino
iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan-L study. Diabetes, obesity & metabolism 22 (9) (2020)
Irene Caruso, Francesco Giorgino
The diabetic lung: An easy target for SARS-CoV-2? Diabetes/metabolism research and reviews 36 (8) (2020)
S Porro, V A Genchi, A Cignarelli, A Natalicchio, L Laviola, Francesco Giorgino, S Perrini
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects. Journal of endocrinological investigation 44 (5) (2020)
Irene Caruso, Sergio Di Molfetta, Francesca Guarini, Fiorella Giordano, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Anna Leonardini, Francesco Giorgino, Luigi Laviola
Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes. Diabetes/metabolism research and reviews 37 (6) (2020)
Sebastio Perrini, Stefania Porro, Pasquale Nigro, Angelo Cignarelli, Cristina Caccioppoli, Valentina Annamaria Genchi, Gennaro Martines, Michele De Fazio, Palma Capuano, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity. International journal of obesity (2005) 44 (2) (2019)
Francesca Conserva, Mariagrazia Barozzino, Francesco Pesce, Chiara Divella, Annarita Oranger, Massimo Papale, Fabio Sallustio, Simona Simone, Luigi Laviola, Francesco Giorgino, Anna Gallone, Paola Pontrelli, Loreto Gesualdo
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy. Scientific reports 9 (1) (2019)
Luca Degli Esposti, Valentina Perrone, Stefania Saragoni, Valerio Blini, Stefano Buda, Rosella D'avella, Gina Gasperini, Fabio Lena, Francesca Fanelli, Luca Gazzi, Francesco Giorgino
Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study. Journal of diabetes research 2019 (2019)
Alice Y Y Cheng, Stewart Harris, Francesco Giorgino, Jochen Seufert, Robert Ritzel, Kamlesh Khunti F MedSci, Felipe Lauand, Lydie Melas-Melt, Jukka Westerbacka, Zsolt Bosnyak, Julio Rosenstock
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study. Diabetes, obesity & metabolism 22 (3) (2019)
Francesco Giorgino, Maria Yu, Axel Haupt, Zvonko Milicevic, Luis-Emilio Garcia-Perez
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial. Diabetes, obesity & metabolism 21 (11) (2019)
Angelo Cignarelli, Valentina Annamaria Genchi, Sebastio Perrini, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Insulin and Insulin Receptors in Adipose Tissue Development. International journal of molecular sciences 20 (3) (2019)
Francesco Giorgino, Alka Shaunik, Minzhi Liu, Aramesh Saremi
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial. Diabetes, obesity & metabolism 21 (12) (2019)
Marco Castellana, Angelo Cignarelli, Francesco Brescia, Francesco Giorgino, Annalisa Natalicchio, Luigi Laviola, Francesco Giorgino
Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis. Scientific reports 9 (1) (2019)
Annalisa Natalicchio, Nicola Marrano, Giuseppina Biondi, Lucia Dipaola, Rosaria Spagnuolo, Angelo Cignarelli, Francesco Giorgino, Luigi Laviola, Francesco Giorgino
Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brain. Diabetes/metabolism research and reviews 36 (3) (2019)
Paola Fioretto, Stephano Del Prato, John B Buse, Ronald Goldenberg, Francesco Giorgino, Daniel Reyner, Anna Maria Langkilde, C David Sjöström, Peter Sartipy, null null
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study. Diabetes, obesity & metabolism 20 (11) (2018)
Julio Rosenstock, Yehuda Handelsman, Josep Vidal, F Javier Ampudia Blasco, Francesco Giorgino, Minzhi Liu, Riccardo Perfetti, Juris J Meier
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes. Diabetes, obesity & metabolism 20 (12) (2018)
Marco Castellana, Angelo Cignarelli, Francesco Brescia, Luigi Laviola, Francesco Giorgino
GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis. Diabetes/metabolism research and reviews 35 (1) (2018)
Annalisa Natalicchio, Nicola Marrano, Giuseppina Biondi, Rosaria Spagnuolo, Rossella Labarbuta, Immacolata Porreca, Angelo Cignarelli, Marco Bugliani, Piero Marchetti, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
The Myokine Irisin Is Released in Response to Saturated Fatty Acids and Promotes Pancreatic β-Cell Survival and Insulin Secretion. Diabetes 66 (11) (2017)